Human Genome Epidemiology Literature Finder
|
Records 1 - 12 (of 12 Records) |
| Query Trace: Thrombosis and EGFR[original query] |
|---|
| Mutations in NSCLC and their link with lung cancer-associated thrombosis: a case-control study. Thrombosis research 2014 Jan 133 (1): 48-51. Corrales-Rodriguez Luis, Soulières Denis, Weng Xiaoduan, Tehfe Mustapha, Florescu Marie, Blais Norma |
| Association of impaired renal function with venous thrombosis: A genetic risk score approach. Thrombosis research 2017 Aug 158 102-107. Charmet Romain, van Hylckama Vlieg Astrid, Germain Marine, Roussel Ronan, Marre Michel, Debette Stéphanie, Amouyel Philippe, Deleuze Jean-François, Hadjadj Samy, Rosendaal Frits R, Morange Pierre-Emmanuel, Trégouët David-Alexand |
| Risk of thromboembolism in patients with ALK- and EGFR-mutant lung cancer: A cohort study. Journal of thrombosis and haemostasis : JTH 2020 12 19 (3): 822-829. Roopkumar Joanna, Poudel Shyam K, Gervaso Lorenzo, Reddy Chandana A, Velcheti Vamsidhar, Pennell Nathan A, McCrae Keith R, Khorana Alok |
| Efficacy of nintedanib plus docetaxel in patients with refractory advanced epidermal growth factor receptor mutant lung adenocarcinoma. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2021 Jul . Riudavets Mariona, Bosch-Barrera Joaquim, Cabezón-Gutiérrez Luís, Diz Taín Pilar, Hernández Ainhoa, Alonso Miriam, Blanco Remei, Gálvez Elisa, Insa Amelia, Mielgo Xabier, Morán Teresa, Ponce Santiago, Roa Diana, Sánchez José Miguel, Majem Margari |
| Concurrent chemotherapy and first-generation epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) with or without an antiangiogenic agent as first-line treatment in advanced lung adenocarcinoma harboring an EGFR mutation. Thoracic cancer 2021 6 12 (16): 2233-2240. Xu Ziyi, Hao Xuezhi, Lin Lin, Li Junling, Xing Puyu |
| Phase II study evaluating the association of gemcitabine, trastuzumab and erlotinib as first-line treatment in patients with metastatic pancreatic adenocarcinoma (GATE 1). International journal of cancer 2021 Feb 148 (3): 682-691. Assenat Eric, Mineur Laurent, Mollevi Caroline, Lopez-Crapez Evelyne, Lombard-Bohas Catherine, Samalin Emmanuelle, Portales Fabienne, Walter Thomas, de Forges Hélène, Dupuy Marie, Boissière-Michot Florence, Ho-Pun-Cheung Alexandre, Ychou Marc, Mazard Thiba |
| Common genetic driver mutation in NSCLC and their association with thromboembolic events: A retrospective study. Lung cancer (Amsterdam, Netherlands) 2022 10 172 29-34. Lin Miaozhen, Lu Yujuan, Yu Qiwen, Chen Zebin, Peng Jiayu, Cai Xiu |
| Genetics of osteopontin in patients with chronic kidney disease: The German Chronic Kidney Disease study. PLoS genetics 2022 4 18 (4): e1010139. Cheng Yurong, Li Yong, Scherer Nora, Grundner-Culemann Franziska, Lehtimäki Terho, Mishra Binisha H, Raitakari Olli T, Nauck Matthias, Eckardt Kai-Uwe, Sekula Peggy, Schultheiss Ulla T, |
| Risk of thromboembolism in non-small-cell lung cancers patients with different oncogenic drivers, including ROS1, ALK, and EGFR mutations. ESMO open 2022 Dec 7 (6): 100742. Wang H-Y, Wu S-G, Lin Y-T, Chen C-Y, Shih J |
| Genomic and clinicopathological features of lung adenocarcinomas with micropapillary component. Frontiers in oncology 2022 12 12 989349. Li Peng, Liu Lu, Wang Dong, Yang Ronghua, Xuan Yunpeng, Han Yudong, Wang Jinglong, Guo Lijie, Zhang Liwen, Zhang Shanshan, Wang Yongj |
| Safety and Efficacy of CYP2C19 Genotype-Guided Escalation of P2Y Inhibitor Therapy After Percutaneous Coronary Intervention in Chronic Kidney Disease: a Post Hoc Analysis of the TAILOR-PCI Study. Cardiovascular drugs and therapy 2022 11 . Mathew Roy O, Sidhu Mandeep S, Rihal Charanjit S, Lennon Ryan, El-Hajjar Mohammed, Yager Neil, Lyubarova Radmila, Abdul-Nour Khaled, Weitz Steven, O'Cochlain D Fearghas, Murthy Vishakantha, Levisay Justin, Marzo Kevin, Graham John, Dzavik Vlad, So Derek, Goodman Shaun, Rosenberg Yves D, Pereira Naveen, Farkouh Michael |
| Circulating tumor DNA predicts venous thromboembolism in patients with cancers. Journal of thrombosis and haemostasis : JTH 2024 9 . Shengling Ma, Jun Y Jiang, Rock Bum Kim, Elizabeth Chiang, Joyce Wan Theng Tiong, Justine Ryu, Danielle Guffey, Raka Bandyo, Heidi Dowst, Kaitlin N Swinnerton, Nathanael R Fillmore, Jennifer La, Ang |
- Page last reviewed:Feb 1, 2024
- Content source: